Wolverine Trading’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Wolverine Trading’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-40,332	Closed	-$561K	–	5569
2020 Q1	$294K	Buy	40,332 +9,871	+32%	+$123K	﹤0.01%	3244
2019 Q4	$726K	Buy	30,461 +9,981	+49%	+$275K	﹤0.01%	2723
2019 Q3	$549K	Sell	20,480 -6,265	-23%	-$176K	﹤0.01%	2541
2019 Q2	$726K	Sell	26,745 -4,091	-13%	-$128K	﹤0.01%	2337
2019 Q1	$1.07M	Sell	30,836 -24,222	-44%	-$699K	﹤0.01%	2013
2018 Q4	$941K	Buy	55,058 +27,846	+102%	+$573K	﹤0.01%	2024
2018 Q3	$725K	Buy	+27,212	New	+$888K	﹤0.01%	2687

Wolverine Trading's PTLA Position: Q2 2020 in Review

Wolverine Trading sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 40,332 shares — an estimated $561K sold.

Wolverine Trading first reported a position in PTLA in Q3 2018 and held it in 7 quarters. The position peaked at $1.07M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

Wolverine Trading reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
Wolverine Trading sold 40,332 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $561K.
Wolverine Trading first reported a position in Portola Pharmaceuticals, Inc. in Q3 2018 and held it in 7 quarters.
Wolverine Trading's Portola Pharmaceuticals, Inc. position peaked at $1.07M in Q1 2019.
162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on Wolverine Trading's 13F filing for Q2 2020, filed 13 Aug 2020.